Related Experiment Video
Updated: Oct 11, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections
Matteo Bassetti1,2, Javier Garau3,4
1Clinica Malattie Infettive, Ospedale Policlinico San Martino-IRCCS, Genoa, Italy.
Abstract:
Microbial resistance is a serious threat to human health worldwide. Among the World Health Organisation's list of priority resistant bacteria, three are listed as critical-the highest level of concern-and all three are Gram-negative. Gram-negative resistance has spread worldwide via a variety of mechanisms, the most problematic being via AmpC enzymes, extended-spectrum β-lactamases, and carbapenemases. A combination of older drugs, many with high levels of toxicity, and newer agents are being used to combat multidrug resistance, with varying degrees of success. This review discusses the current treatments for multidrug-resistant Gram-negative bacteria, including new agents, older compounds, and new combinations of both, and some new treatment targets that are currently under investigation.
Insights
Multidrug-resistant Gram-negative bacteria pose a critical global health threat. This review examines current and emerging treatments, including novel drugs and combinations, to combat these challenging infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antimicrobial resistance is a significant global health concern.
- Gram-negative bacteria are a major source of critical priority pathogens.
- Mechanisms of resistance include AmpC enzymes, extended-spectrum β-lactamases, and carbapenemases.
Purpose of the Study:
- To review current therapeutic strategies for multidrug-resistant Gram-negative bacteria.
- To discuss novel antimicrobial agents and treatment combinations.
- To explore emerging therapeutic targets for Gram-negative infections.
Main Methods:
- Literature review of current treatments for multidrug-resistant Gram-negative bacteria.
- Analysis of new agents, older compounds, and combination therapies.
- Investigation of new treatment targets under research.
Main Results:
- Existing treatments for multidrug-resistant Gram-negative bacteria show variable success.
- New antimicrobial agents and combination therapies are being developed.
- Novel treatment targets are under investigation to overcome resistance.
Conclusions:
- Combating multidrug-resistant Gram-negative bacteria requires a multifaceted approach.
- Continued research into new drugs, combinations, and targets is essential.
- Addressing this global health threat necessitates innovative therapeutic strategies.
More Related Videos
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Microorganisms in Medicine and Therapeutics
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy